Policy changes Backwork has recorded, newest first. The most recent change on record is from October 2, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
79,474 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Atidarsagene Autotemcel (Lenmeldy) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Atezolizumab and Hyaluronidase-tqjs (Tecentria Hybreza) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Atezolizumab (Tecentriq) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Calaspargase Pegol-mknl (Asparlas) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Asparaginase Erwinia chrysanthemi (recombinant)-rywn (Rylaze) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Artificial Intervertebral Disc | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Diagnosis and Treatment of Sacroiliac Joint Pain | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Subtalar Arthroereisis | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | End Diastolic Pneumatic Compression Boot as a Treatment of Peripheral Vascular Disease or Lymphedema | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nelarabine (Arranon) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Darbepoetin Alfa (Aranesp) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Aqueous Shunts and Stents for Glaucoma | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Motixafortide (Aphexda) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Ovarian Cancer Tumor Markers | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nogapendekin Alfa-Inbakicept-pmln (Anktiva) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Total Ankle Replacement | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Anifrolumab-fnia (Saphnelo) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Angioplasty or Stenting for Intracranial Arterial Disease (Atherosclerosis and Aneurysms) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Disorders | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Vutrisiran (Amvuttra) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Lifileucel (Amtagvi) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Cytochrome p450 Genotyping | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Casimersen (Amondys 45) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Human Amniotic Membrane Grafts and Amniotic Fluid Injections | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Amivantamab and Hyaluronidase-lpuj (Rybrevant Faspro) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Amivantamab-vmjw (Rybrevant) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Complementary and Alternative Medicine | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Alpha-1 Proteinase Inhibitor (Aralast NP, Glassia, Prolastin-C, Zemaira) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Osteochondral Allografting | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Meniscal Allografts and Synthetic Meniscus Implants | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Allogeneic Regulatory T Cell Immunotherapy with HSPC and T cells-vldq (Tregzi) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Allogeneic Processed Thymus Tissue-agdc (Rethymic) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Bioengineered Skin and Soft Tissue Substitutes | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Allergy Testing - Leukocyte Histamine Release Test (LHRT) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Conjunctival Challenge Test | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Alglucosidase Alfa (Lumizyme) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Alemtuzumab (Lemtrada) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Laronidase (Aldurazyme) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Aldesleukin IL‐2 (Proleukin) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Agalsidase Beta(Fabrazyme) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Aflibercept Products (Eylea; EyleaHD, Ahzantive [aflibercept-mrbb], Enzeevu [Aflibercept-abzv], Eydenzelt [Aflibercept-boav], Opuviz [Aflibercept-yszy], Pavblu [Aflibercept-ayyh], and Yesafili [Aflibercept-jbvf]) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Afamitresgene Autoleucel (Tecelra) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Aducanumab-avwa (Aduhelm) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Nadofaragene firadenovec-vncg (Adstiladrin) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Adoptive Immunotherapy | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Ado-Trastuzumab Emtansine (Kadcyla) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Adipose-Derived Stem Cells in Autologous Fat Grafting to the Breast | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Brentuximab Vedotin (Adcetris) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | ADAMTS13, recombinant-krhn (Adzynma) | Metadata changed |
| Oct 2, 2026 | BlueCross BlueShield of Tennessee | Crizanlizumab-tmca(Adakveo) | Metadata changed |